Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Immunoglobulin G4-Related Disease
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
- A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
- A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease
- Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
- A Study of Efgartigimod in Patients With IgG4-Related Disease
- A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
- Short-term Glucocorticoid Combined with MMF for IgG4-RD
- Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
- The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
- Baricitinib Plus Glucocorticoid for Eosinophilia in IgG4-RD
- Study of Sirolimus in IgG4-related Disease
- A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
- Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
- Belimumab Treatment for IgG4-related Disease
- Zanubrutinib in Patients With IgG4-Related Disease
- A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
- Open Label Two-Arm Study to Evaluate Rilzabrutinib (PRN1008) in IgG4-Related Disease Patients
- Characterizing IgG4-RD With 68Ga-FAPI PET/CT
- Withdraw Drug in Stable IgG4-Related Disease
- Safety and Efficacy of Abatacept in IgG4-Related Disease
- To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom
- Treatment of IgG4-Related Disease With Revlimid and Rituximab
- Leflunomide for Maintenance of Remission in IgG4 Related Disease
- Study of Treatment Response on IgG4 Related Disease (IgG4RD)
- Glucocorticoids in Patients With IgG4-RD
- 18F-FDG PET/CT for IgG4-Related Disease